May 10, 2021 05:57 PM IST
BioNTech chief executive Ugur Sahin had said in April that the vaccine works against the Indian variant.
- May 10, 2021 01:35 PM IST
The vaccine has yet to be approved in mainland China, where regulations require an in-country clinical trial. BioNTech’s CEO has said the company expects the shot to be approved in July.
- Apr 28, 2021 06:12 PM IST
While the exact threshold required to reach that critical level of immunization remains a matter of debate, experts say a level above 70 percent would significantly disrupt transmission of the coronavirus within a population.
- Apr 10, 2021 09:02 AM IST
New York-based Pfizer and BioNTech SE of Germany have asked the US Food and Drug Administration to expand the emergency use authorisation for their vaccine to include adolescents ages 12 through 15.
- Mar 30, 2021 04:31 PM IST
The company said the boost would allow it to "address increased demand" as countries around the world race to contain new, more contagious virus variants.
- Mar 19, 2021 08:15 PM IST
Ozlem Tureci, who founded the German company BioNTech with her husband Ugur Sahin, was working on a way to harness the body’s immune system to tackle tumors when they learned last year of an unknown virus infecting people in China.
- Mar 02, 2021 07:49 PM IST
Seth Berkley, CEO of the GAVI alliance that co-leads the COVAX multilateral vaccine facility with the World Health Organization (WHO), told journalists the requirements were partly related to indemnification issues.
- Feb 26, 2021 02:57 PM IST
Many people — including health workers — are skipping appointments or refusing to sign up for the AstraZeneca shot, which they fear is less effective than the Pfizer-BioNTech vaccine
- Feb 19, 2021 07:12 PM IST
Pfizer/BioNTech’s vaccine, along with Moderna Inc’s two-dose vaccine, won the U.S. emergency use authorization (EUA) and is being widely distributed as part of the country’s mass vaccination efforts.
- Feb 19, 2021 06:28 PM IST
The Sheba Medical Center's findings compare with overall efficacy of around 95% in a two dose regimen 21 days apart for the shot developed with Germany's BioNTech.
- Jan 26, 2021 03:19 PM IST
AstraZeneca's announcement that it will deliver fewer vaccines to the EU early on has only increased pressure on the 27-nation bloc, especially since Pfizer-BioNTech, the first vaccine to get EU approval, failed last week to keep up its promised deliveries to the EU.
- Jan 25, 2021 08:56 PM IST
India's CDSCO says Pfizer officials failed to turn up to meetings after the company's application was made in early December. The regulator has also declined to accept the company's request for approval without a small local trial on the vaccine's safety and immunogenicity for Indians
- Jan 20, 2021 04:15 PM IST
The research team led by BioNTech Chief Executive Officer Ugur Sahin has said the result of the study proves it is very unlikely that the UK variant viruses will be able to dodge the Pfizer COVID-19 vaccine.
- Jan 15, 2021 10:25 PM IST
At the Meissen crematorium in Germany's Saxony state, coffins were stacked up to three high, or even stored in hallways, awaiting cremation.
- Jan 11, 2021 07:45 PM IST
"We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated 6-dose label," BioNTech said in a presentation.
- Jan 05, 2021 06:12 PM IST
BioNTech, which developed the vaccine with US giant Pfizer, said its clinical data showing 95 percent efficacy was based on a two-dose schedule separated by 21 days.
- Jan 03, 2021 08:57 AM IST
A 32-year-old doctor in Mexico has been admitted to the intensive care unit (ICU) due to severe medical allergy to the Pfizer-BioNTech vaccine
- Jan 02, 2021 08:55 AM IST
Eyebrows have been raised in Germany where inoculation drives had to be halted due to the late rollout – despite the COVID-19 vaccine being indigenously developed.
- Jan 02, 2021 05:20 AM IST
Trial participants who received the placebo will have two doses of the investigational vaccine reserved for them within the study, the companies said on the website.
- Dec 27, 2020 10:46 PM IST
But surveys have pointed to high levels of hesitancy towards inoculation in countries from France to Poland, with many used to vaccines taking decades to develop, not just months.
- Dec 27, 2020 08:17 PM IST
Amid the global scramble to solve the problem of keeping vaccines at the right temperature as they get transported across the world, it would appear that there is a German company for every obscure application.
- Dec 26, 2020 10:47 PM IST
Sahin repeated BioNTech aimed to distribute 1.3 billion doses of its vaccine by the end of 2021 and that 70 percent of the world needed to be vaccinated by next winter to go back to "normal life".
- Dec 22, 2020 04:00 PM IST
The European Union is gearing up for a vaccination campaign of unprecedented scale following regulatory approval for the shot on Monday.
- Dec 19, 2020 10:25 AM IST
Both the Pfizer/BioNTech and Moderna's COVID-19 vaccines target the crown-like spikes on the surface of the novel coronavirus that it uses to break into healthy human cells. So, how are they different?
- Dec 16, 2020 03:21 PM IST
China has been rapidly developing its own COVID-19 vaccine candidates and ramping up production facilities, but local firms have also been partnering with foreign developers to supply the world's most populous country.